Search for Clinical Trial Results
Pleural Effusion, Malignant - 25 Studies Found
Status | Study |
Recruiting |
Study Name: Bevacizumab in the Treatment of Malignant Pleural Effusions of Non-squamous Non-small Cell Lung Cancer Condition: Malignant Pleural Effusion Date: 2016-10-18 Interventions: Drug: Bevacizumab Group A (low dose group) Intrapleural in |
Completed |
Study Name: A Quality of Life Study re Management of Malignant Pleural Effusions Condition: Malignant Pleural Effusions Date: 2005-09-12 Interventions: Behavioral: LCADLS, FACIT-PAL, FACIT-TS questionnaires LCADLS, FACIT-PAL, FACIT-TS questionnaires |
Recruiting |
Study Name: Using Thoracic Ultrasound to Predict Pleurodesis Success in Malignant Pleural Effusions: a Pilot Study Condition: Malignant Pleural Effusion Date: 2015-10-21 Interventions: Other: Ultrasound scan |
Recruiting |
Study Name: Efficacy and Safety of Bevacizumab Versus Pulvis Talci in Malignant Pleural Effusion Condition: Malignant Pleural Effusion Date: 2014-01-28 Interventions:
|
Completed |
Study Name: Efficacy and Safety Study of Abnoba Viscum F 20mg in Malignant Pleural Effusion Patients Condition: Malignant Pleural Effusion Date: 2014-07-14 Interventions: Drug: Abnoba Viscum F 20mg intravesical instillation of five amples of AbnobaViscum® F20mg and 0.9% |
Recruiting |
Study Name: A Study to Compare the Efficacy and Safety of Intrapleural Doxycycline Versus Iodopovidone for Performing Pleurodesis in Malignant Pleural Effusion Condition: Malignant Pleural Effusion Date: 2015-08-04 Interventions:
|
Completed |
Study Name: Talc Pleurodesis in Patients With Recurrent Malignant Pleural Effusion Condition: Recurrent Malignant Pleural Effusion. Date: 2008-11-10 Interventions:
|
Completed |
Study Name: Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer Condition: Malignant Pleural Effusion Date: 2012-07-25 Interventions:
|
Recruiting |
Study Name: A Clinical Study Evaluating the Safety and Effectiveness of a New Pleural Catheter for the Medical Management of Symptomatic, Recurrent, Malignant Pleural Effusions Compared to Approved Pleural Catheter. Condition: Malignant Pleural Effusion Date: 2015-12-18 Interventions: Device: Indwelling Pleural Catheter |
Terminated |
Study Name: Zometa Adjuvant Treatment of Malignant Pleural Effusion Due To Non-Small Cell Lung Cancer Condition:
Interventions: Drug: zoledronic acid Zoledronic acid (Zometa) 4mg IV every 4 weeks for 3 treatments with chemotherapy a |